Literature DB >> 12969266

Acetylcholinesterase induces neuronal cell loss, astrocyte hypertrophy and behavioral deficits in mammalian hippocampus.

Marcelo A Chacón1, Ariel E Reyes, Nibaldo C Inestrosa.   

Abstract

Previous studies have demonstrated that acetylcholinesterase (AChE) promotes the assembly of amyloid-beta-peptides into neurotoxic amyloid fibrils and is toxic for chick retina neuronal cultures and neuroblastoma cells. Moreover, AChE is present in senile plaques in Alzheimer's disease (AD) brains. Here we have studied the effect of AChE on astrocytes and hippocampal neurons in vivo. Morphological as well as behavioral disturbances were analyzed after intrahippocampal injection of AChE. Rats were trained in the Morris water maze and assayed for behavioral parameters. Neuronal cell loss was found in the upper leaf of the dentate gyrus in rats injected with AChE in comparison with control animals. Glial fibrillary acidic protein immunoreactivity showed astrocytic hypertrophy and the magnitude of the response was associated with neuronal cell loss. Behavioral results show that injection of AChE produces cognitive impairment demonstrated by an altered water maze performance including (i) a higher escape latency score, (ii) a decreased spatial acuity and (iii) a shorter time of swimming in the platform quadrant. These findings indicate that a local increment in neuronal AChE concentration at the mammalian hippocampus, such as those present in amyloid deposits, may play a role in triggering neuropathological and behavioral changes such as those observed in AD brains.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12969266     DOI: 10.1046/j.1471-4159.2003.01985.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  Regional acetylcholinesterase activity and its correlation with behavioral performances in 15-month old transgenic mice expressing the human C99 fragment of APP.

Authors:  M Dumont; R Lalonde; J-F Ghersi-Egea; K Fukuchi; C Strazielle
Journal:  J Neural Transm (Vienna)       Date:  2005-12-14       Impact factor: 3.575

2.  Amyloid-beta-Acetylcholinesterase complexes potentiate neurodegenerative changes induced by the Abeta peptide. Implications for the pathogenesis of Alzheimer's disease.

Authors:  Margarita C Dinamarca; Juan P Sagal; Rodrigo A Quintanilla; Juan A Godoy; Macarena S Arrázola; Nibaldo C Inestrosa
Journal:  Mol Neurodegener       Date:  2010-01-18       Impact factor: 14.195

3.  Exploring the mechanisms of graphene oxide behavioral and morphological changes in zebrafish.

Authors:  Zaira Clemente; Gabriela Helena Silva; Miriam Celi de Souza Nunes; Diego Stéfani Teodoro Martinez; Claudia Vianna Maurer-Morelli; Andre Alexandre Thomaz; Vera Lúcia Scherholz Salgado Castro
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-28       Impact factor: 4.223

4.  Curcumin improves episodic memory in cadmium induced memory impairment through inhibition of acetylcholinesterase and adenosine deaminase activities in a rat model.

Authors:  Ayodele Jacob Akinyemi; Princess Kamsy Okonkwo; Opeyemi Ayodeji Faboya; Sunday Amos Onikanni; Adewale Fadaka; Israel Olayide; Elizabeth Olufisayo Akinyemi; Ganiyu Oboh
Journal:  Metab Brain Dis       Date:  2016-08-05       Impact factor: 3.584

5.  Neuroprotective efficacy of eugenol and isoeugenol in acrylamide-induced neuropathy in rats: behavioral and biochemical evidence.

Authors:  Sathya N Prasad
Journal:  Neurochem Res       Date:  2012-11-17       Impact factor: 3.996

6.  Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss.

Authors:  Ariel E Reyes; Marcelo A Chacón; Margarita C Dinamarca; Waldo Cerpa; Carlos Morgan; Nibaldo C Inestrosa
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

7.  Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.

Authors:  Francisco J Carvajal; Nibaldo C Inestrosa
Journal:  Front Mol Neurosci       Date:  2011-09-14       Impact factor: 5.639

8.  Cerebrospinal fluid (CSF) 25-hydroxyvitamin D concentration and CSF acetylcholinesterase activity are reduced in patients with Alzheimer's disease.

Authors:  Per Johansson; Erik G Almqvist; Jan-Ove Johansson; Niklas Mattsson; Ulf Andreasson; Oskar Hansson; Anders Wallin; Kaj Blennow; Henrik Zetterberg; Johan Svensson
Journal:  PLoS One       Date:  2013-11-29       Impact factor: 3.240

9.  Effect of Proline on Cell Death, Cell Cycle, and Oxidative Stress in C6 Glioma Cell Line.

Authors:  Andréa Gisiane Kurek Ferreira; Helena Biasibetti-Brendler; Daniele Susana Volkart Sidegum; Samanta Oliveira Loureiro; Fabrício Figueiró; Angela T S Wyse
Journal:  Neurotox Res       Date:  2020-11-16       Impact factor: 3.911

10.  Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer's Disease.

Authors:  Angel Agis-Torres; Monica Sölhuber; Maria Fernandez; J M Sanchez-Montero
Journal:  Curr Neuropharmacol       Date:  2014-01       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.